ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,420.26
-0.22%
Dow Jones
40,003.59
0.34%
Gold vs US Dollar
2,413.935
0.00%
Brent Oil
83.76
0.00%
Bitcoin
67,128.56
0.28%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. MEI Pharma Inc (MEIP)

  7. MEI Pharma Inc (MEIP) News

MEI Pharma (MEIP)

MEI Pharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:MEIP
DateTimeSourceHeadlineSymbolCompany
09/05/202421:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MEIPMEI Pharma Inc
09/05/202421:02Business WireMEI Pharma Reports Third Quarter Fiscal Year 2024 Results and Operational HighlightsNASDAQ:MEIPMEI Pharma Inc
09/05/202421:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MEIPMEI Pharma Inc
11/04/202413:02Business WireMEI Pharma Board of Directors Aligns on Strategy to Advance Voruciclib and ME-344NASDAQ:MEIPMEI Pharma Inc
11/04/202413:00Business WireMEI Pharma Reports Initial Data from Clinical Study Evaluating ME-344 in Combination with Bevacizumab (Avastin®) in Relapsed Metastatic Colorectal Cancer PatientsNASDAQ:MEIPMEI Pharma Inc
10/04/202413:00Business WireMEI Pharma to Present at the Stifel 2024 Virtual Targeted Oncology ForumNASDAQ:MEIPMEI Pharma Inc
26/03/202412:00Business WireMEI Pharma Reports Update from Clinical Study Evaluating Oral CDK9 Inhibitor Voruciclib in Combination with Venetoclax in Patients with Relapsed and Refractory Acute Myeloid LeukemiaNASDAQ:MEIPMEI Pharma Inc
29/02/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:MEIPMEI Pharma Inc
21/02/202421:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MEIPMEI Pharma Inc
20/02/202422:33Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:MEIPMEI Pharma Inc
13/02/202422:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MEIPMEI Pharma Inc
13/02/202422:05Business WireMEI Pharma Reports Second Quarter Fiscal Year 2024 Results and Operational HighlightsNASDAQ:MEIPMEI Pharma Inc
17/01/202421:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MEIPMEI Pharma Inc
16/01/202422:00Business WireMEI Pharma to Present Design of Ongoing Clinical Study Evaluating ME-344 at ASCO GI Cancers Symposium 2024NASDAQ:MEIPMEI Pharma Inc
12/01/202421:00Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:MEIPMEI Pharma Inc
12/01/202421:00Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:MEIPMEI Pharma Inc
26/12/202322:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MEIPMEI Pharma Inc
22/12/202321:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MEIPMEI Pharma Inc
21/12/202302:26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MEIPMEI Pharma Inc
21/12/202302:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MEIPMEI Pharma Inc
18/12/202321:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MEIPMEI Pharma Inc
11/12/202321:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MEIPMEI Pharma Inc
11/12/202317:00Business WireMEI Pharma Reports Clinical Data on Oral CDK9 Inhibitor Voruciclib at ASH2023NASDAQ:MEIPMEI Pharma Inc
15/11/202301:59Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MEIPMEI Pharma Inc
09/11/202321:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MEIPMEI Pharma Inc
09/11/202321:05Business WireMEI Pharma Reports First Quarter Fiscal Year 2024 Results and Operational HighlightsNASDAQ:MEIPMEI Pharma Inc
09/11/202321:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MEIPMEI Pharma Inc
08/11/202322:04Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:MEIPMEI Pharma Inc
08/11/202322:03Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:MEIPMEI Pharma Inc
08/11/202322:02Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:MEIPMEI Pharma Inc
 Showing the most relevant articles for your search:NASDAQ:MEIP

Your Recent History

NASDAQ
ATPG
NASDAQ
FREQ
Frequency Therapeutics
CSE
PLUS
Plus Products
COIN
GRTZUST
Guaranteez Token
ASX
VEUSON
BITMOT
864895
Bund Tf 0% Mg35 Eur
USOTC
TMSNY
Temenos (PK)
ASX
FXPKOC
CSE
IDK
ThreeD Capital
ASX
VKAN
LSE
XMID
Xindonesiasw 1c
NYSE
ACHR
Archer Aviation
LSE
0R2N
RTX
LATK
BTSBTC
BitShares
LSE
MAB1
Mortgage Advice Bureau (...
UNSW3
SILOETH
Silo Governance Token
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved